Deal facts
- Buyer
- Medpal AI plc
- Target
- Universal Pharmacy Ltd
- Deal value
- GBP 45,000
- Announced
- 16 February 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- United Kingdom
- Consideration
- cash
Sources
Medpal AI plc has agreed to acquire Universal Pharmacy Ltd in a strategic acquisition valued at £45,000. The transaction was settled entirely in cash and relates to the pharmacy and healthcare services sector. Although the deal was announced on 16 February 2026, the completion date is recorded as 13 February 2026. The target company operates within the United Kingdom, and the buyer is a public limited company focused on artificial intelligence solutions for the industry.
The acquisition represents a significant expansion for the buyer into physical retail healthcare services. Both parties have confirmed that the transaction has been completed as of the stated date. The deal structure involves a straightforward purchase of the target business without any complex earn-out provisions or debt assumptions reported in the available data. The transaction is now final and the target operates as a subsidiary of the acquiring entity.
Weekly digest
Join Exit Mode Insider
Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.
Join Exit Mode Insider, £12/moDeal timeline
1 update- CompletedClosed
Medpal AI plc to acquire Universal Pharmacy Ltd
{ "headline": "Completion of Acquisition", "issuer": "Medpal AI PLC (MPAL)", "announcement_date": "2026-02-16T07:00:00", "category_code": "Completion of Acquisition", "body": "Disclaimer* \n\n 16 February 2026 \n\n Medal AI plc \n\n (\"MedPal AI\" or the \"Company\") \n\n Completion of Acquisition of Universal Pharmacy assets and Expansion of Robotic Distribution Facility in Swaffham \n\
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Shuttle Pharmaceuticals Holdings, Inc. to acquire United Dogecoin Inc.
Shuttle Pharmaceuticals Holdings, Inc. and United Dogecoin Inc. entered the Exit Mode archive.
- Buyer
- Shuttle Pharmaceuticals Holdings, Inc.
- Target
- United Dogecoin Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
MedPal AI plc to acquire Remedi Solutions Limited
MedPal AI plc and Remedi Solutions Limited entered the Exit Mode archive.
- Buyer
- MedPal AI plc
- Target
- Remedi Solutions Limited
- Deal value
- GBP 310,000
- Deal type
- strategic acquisition
BIOMARIN PHARMACEUTICAL INC to acquire Amicus
BIOMARIN PHARMACEUTICAL INC and Amicus entered the Exit Mode archive.
- Buyer
- BIOMARIN PHARMACEUTICAL INC
- Target
- Amicus
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Telomir Pharmaceuticals, Inc. to acquire TELI Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. and TELI Pharmaceuticals, Inc. entered the Exit Mode archive.
- Buyer
- Telomir Pharmaceuticals, Inc.
- Target
- TELI Pharmaceuticals, Inc.
- Deal value
- USD 34,389,710
- Deal type
- strategic acquisition
GSK plc to acquire 35Pharma Inc.
GSK plc has agreed to acquire 35Pharma Inc., a Canadian biopharmaceutical company, for an equity value of USD 950 million. The transaction was structured as a strategic…
- Buyer
- GSK plc
- Target
- 35Pharma Inc.
- Deal value
- USD 950,000,000
- Deal type
- strategic acquisition
Buyer history
Medpal AI plc
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive
